ACTIVE

FOR PLUS PHARMA

Financial year 2024 · closed on 31/12/2024
Net result
1,2 k €
+102.4% YoY
Gross margin
19,5 k €
+161.6% YoY
Equity
17,2 k €
+7.5% YoY

What does FOR PLUS PHARMA do?

FOR PLUS PHARMA is a Private limited company incorporated in 2020. Its registered office is in Erquelinnes.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0743.663.465
Incorporation
14/02/2020
Legal form
Private limited company
Registered office
Espace Européen d'Entreprises 17 box B
6560 Erquelinnes · WallonieSee on map
Contributed capital
5 000,00 €
Latest accounts
31/12/2024
Signals
ProfitablePositive cashflowPositive EBITDA
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 5 financial years

20242023202220212020
Income statement
Gross margin19,5 k €-31,7 k €-309 €-30,4 k €151,1 k €
EBITDA5,9 k €-33 k €-821,5 €-30,7 k €150,7 k €
Operating result2,6 k €-36,7 k €-4,6 k €-34,5 k €149,1 k €
Net result1,2 k €-49,3 k €-7,2 k €-38,8 k €106,2 k €
Balance sheet
Equity17,2 k €16 k €65,2 k €72,4 k €111,2 k €
Total assets247,9 k €252,9 k €257,7 k €283,3 k €298,4 k €
Debts230,7 k €237 k €192,5 k €210,9 k €187,2 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 1 ended

Active mandates

STEPHANE CAMBRAYE

Director · since 14 février 2020

Active

Ended mandates

GIANNI SLAVIERO

Director · since 13 avril 2020

Ended
At this address

Other companies at this address

CompanyCBE no.
EGC IMMOActive
0889.352.616
Annual accounts

Full financial information

20242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202401/01/202301/01/202201/01/202114/02/2020
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months11 months
Filing date19/09/202516/05/202513/11/202305/01/202323/12/2022
General meeting06/06/202514/05/202504/10/202305/01/202323/12/2022
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

5 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202406/06/202519/09/2025FrenchPDF
Micro model31/12/202314/05/202516/05/2025FrenchPDF
Micro model31/12/202204/10/202313/11/2023FrenchPDF
Micro model31/12/202105/01/202305/01/2023FrenchPDF
Micro model31/12/202023/12/202223/12/2022FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 1 ended

Active mandates

STEPHANE CAMBRAYE

Director · since 14 février 2020

Active

Ended mandates

GIANNI SLAVIERO

Director · since 13 avril 2020

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 20241,2 k €
  2. 2023
    Annual accounts 2023-49,3 k €
  3. 2022
    Annual accounts 2022-7,2 k €
  4. 2021
    Annual accounts 2021-38,8 k €
  5. 2020
    Annual accounts 2020106,2 k €
  6. 14/02/2020
    IncorporationPrivate limited company